The Union Health Ministry has moved pregabalin under the stricter Schedule H1 category, instead of the existing Schedule H, following reports of misuse and illegal sale in several states. The drug, commonly prescribed for neuropathic pain and neurological conditions, will now require a valid prescription for purchase. Retailers must maintain detailed sales records under the revised regulation.